ACRS Archived Articles

Aclaris Therapeutics (NASDAQ:ACRS): Bolstering its Immuno-Inflammatory Pipeline Through Strategic Licensing


Aclaris Therapeutics (ACRS): Pioneering Innovative Therapies for Immuno-Inflammatory Diseases


Aclaris Therapeutics (ACRS): A Promising Pipeline Targeting Immuno-Inflammatory Diseases